Low Vitamin D Increases Odds of Breast Cancer Spreading by 800 Percent

While many factors may predispose a woman to breast cancer risk, having low vitamin D appears to facilitate cancer’s aggressive spread to other areas of the body, according to research presented this week at the American Association for Cancer Research Conference on the Science of Cancer Health Disparities.

The new research¹ is an extension of earlier research showing that vitamin D levels below 20 are associated with significant breast cancer risk, whereas levels above 40 are associated with reduced risk. The average vitamin D level in women with breast cancer is 27.
In the new research, women with breast cancer whose vitamin D levels were below 20 were eight times as likely to experience the spreading of that cancer compared to women with vitamin D levels above 40. Since spreading of the disease is associated with increased risk of death from breast cancer it seems to only make sense for every woman to ensure that her vitamin D levels are at least 40.

The FDA should allow a health claim for vitamin D and breast cancer risk reduction, as well as to prevent more serious cases of breast cancer. However, the FDA is much more interested in ensuring that the profits of the cancer sickness industry are maintained, which includes having a steady stream of new customers. The Obama FDA is even worse than the Bush FDA in terms of aggressively attacking valid health claims for dietary supplements. When the citizens of the U.S. finally realize the “Earth is not flat” the FDA will be one of the first bureaucracies to be shown the exit.